Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 27, 2024

Effectiveness of Baricitinib vs Tocilizumab in the Treatment of Patients Hospitalized With COVID-19

Critical Care Medicine

 

Additional Info

Critical Care Medicine
Comparative Effectiveness of Baricitinib Versus Tocilizumab in Hospitalized Patients With COVID-19: A Retrospective Cohort Study of the National Covid Collaborative
Crit. Care Med. 2024 Oct 04;[EPub Ahead of Print], AE Patanwala, X Xiao, TE Hills, AM Higgins, CJ McArthur, GC Alexander, HB Mehta

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading